Form 4 for OPRX OptimizeRx Corp
Accepted 2024-06-11 00:00:00 ET · period of report 2024-06-05 · accession 0001628280-24-027712 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-11 | 2024-06-05 | OPRX | HALAS GUS D | Dir | M - OptEx | $0.00 | +10.1K | 80.9K | +14% | $0 |
| D | 2024-06-11 | 2024-06-05 | OPRX | HALAS GUS D | Dir | M - OptEx | $0.00 | -10.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-05 | M | A | 10,061 | $0.00 | 80,926 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2024-06-05 | M | D | 10,061 | $0.00 | 0 | D | — · — to — | 10,061 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024. |